Applying open innovation strategies in the context of a regional innovation ecosystem: The case of Janssen Pharmaceuticals
Open innovation strategies in large firms have been changing considerably during the last 15 years. Some multinationals are now taking a long-term, strategic approach to Open innovation, thereby actively developing a regionally bounded innovation ecosystem. This approach goes beyond the tradition of...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2019-01-01
|
Series: | Global Transitions |
Online Access: | http://www.sciencedirect.com/science/article/pii/S258979181930009X |
id |
doaj-99eaa8303a284c9cb24ddfe674c7c31b |
---|---|
record_format |
Article |
spelling |
doaj-99eaa8303a284c9cb24ddfe674c7c31b2021-04-02T14:27:09ZengKeAi Communications Co., Ltd.Global Transitions2589-79182019-01-011120131Applying open innovation strategies in the context of a regional innovation ecosystem: The case of Janssen PharmaceuticalsJoanna Robaczewska0Wim Vanhaverbeke1Annika Lorenz2Hasselt University, Belgium; Corresponding author.Neoma Business School, Reims, France; ESADE Business School, SpainUtrecht University, Copernicus Institute of Sustainable Development, the NetherlandsOpen innovation strategies in large firms have been changing considerably during the last 15 years. Some multinationals are now taking a long-term, strategic approach to Open innovation, thereby actively developing a regionally bounded innovation ecosystem. This approach goes beyond the tradition of open innovation, which emphasized the opening of firms’ boundaries for inbound and outbound knowledge flows. In the new approach, multinationals actively shape their innovation environment to better exploit external talent and expertise, share public infrastructure, raise funds and influence public policies - the key enablers for establishing a vibrant, world-class research and development (R&D) environment. We examine one such regionally embedded innovation ecosystem set up by Janssen Pharmaceuticals at its global R&D centre in Beerse, Belgium.We develop a conceptual framework by integrating Open innovation, Innovation Ecosystems and Regional Economics literature streams. This combination of the three distinct theoretical approaches is required to explain the benefits and working of Janssen Pharmaceuticals’ regionally embedded innovation ecosystem. Keywords: Open innovation, Innovation ecosystem, Regional innovation system, Pharmaceutical industry, Orchestrator, Strategyhttp://www.sciencedirect.com/science/article/pii/S258979181930009X |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Joanna Robaczewska Wim Vanhaverbeke Annika Lorenz |
spellingShingle |
Joanna Robaczewska Wim Vanhaverbeke Annika Lorenz Applying open innovation strategies in the context of a regional innovation ecosystem: The case of Janssen Pharmaceuticals Global Transitions |
author_facet |
Joanna Robaczewska Wim Vanhaverbeke Annika Lorenz |
author_sort |
Joanna Robaczewska |
title |
Applying open innovation strategies in the context of a regional innovation ecosystem: The case of Janssen Pharmaceuticals |
title_short |
Applying open innovation strategies in the context of a regional innovation ecosystem: The case of Janssen Pharmaceuticals |
title_full |
Applying open innovation strategies in the context of a regional innovation ecosystem: The case of Janssen Pharmaceuticals |
title_fullStr |
Applying open innovation strategies in the context of a regional innovation ecosystem: The case of Janssen Pharmaceuticals |
title_full_unstemmed |
Applying open innovation strategies in the context of a regional innovation ecosystem: The case of Janssen Pharmaceuticals |
title_sort |
applying open innovation strategies in the context of a regional innovation ecosystem: the case of janssen pharmaceuticals |
publisher |
KeAi Communications Co., Ltd. |
series |
Global Transitions |
issn |
2589-7918 |
publishDate |
2019-01-01 |
description |
Open innovation strategies in large firms have been changing considerably during the last 15 years. Some multinationals are now taking a long-term, strategic approach to Open innovation, thereby actively developing a regionally bounded innovation ecosystem. This approach goes beyond the tradition of open innovation, which emphasized the opening of firms’ boundaries for inbound and outbound knowledge flows. In the new approach, multinationals actively shape their innovation environment to better exploit external talent and expertise, share public infrastructure, raise funds and influence public policies - the key enablers for establishing a vibrant, world-class research and development (R&D) environment. We examine one such regionally embedded innovation ecosystem set up by Janssen Pharmaceuticals at its global R&D centre in Beerse, Belgium.We develop a conceptual framework by integrating Open innovation, Innovation Ecosystems and Regional Economics literature streams. This combination of the three distinct theoretical approaches is required to explain the benefits and working of Janssen Pharmaceuticals’ regionally embedded innovation ecosystem. Keywords: Open innovation, Innovation ecosystem, Regional innovation system, Pharmaceutical industry, Orchestrator, Strategy |
url |
http://www.sciencedirect.com/science/article/pii/S258979181930009X |
work_keys_str_mv |
AT joannarobaczewska applyingopeninnovationstrategiesinthecontextofaregionalinnovationecosystemthecaseofjanssenpharmaceuticals AT wimvanhaverbeke applyingopeninnovationstrategiesinthecontextofaregionalinnovationecosystemthecaseofjanssenpharmaceuticals AT annikalorenz applyingopeninnovationstrategiesinthecontextofaregionalinnovationecosystemthecaseofjanssenpharmaceuticals |
_version_ |
1721562254576451584 |